ATAD3A and cancer: Analysis through the online tool Ubinet® suggests that K358 and K573 are the two putative binding sites for ubiquitin on ATAD3A (isoform 2) [45]; however, the underlying mechanisms of ATAD3A expression in cancer remain to be explored.